Danielle Boyle: The Person I Was and the Person I Became After My ITP Diagnosis
Danielle Boyle, Founder and CEO of ITP Australia and New Zealand, reposted from ITP Australia and New Zealand on LinkedIn:
”Who I was before my diagnosis is not the same person I became during my ITP storm, and not the same person I am today.
Taking the time to understand those changes, and accepting that I will keep evolving, doesn’t just shape me.
It changes how I see everything.”
Quoting ITP Australia and New Zealand‘s post:
”A diagnosis doesn’t just alter a patient’s medical pathway – it often reshapes their identity.
Before diagnosis, many individuals see themselves as capable, active and independent.
After diagnosis, their identity may shift toward caution, uncertainty and hyper‑awareness of symptoms.
Over time, many develop a new sense of self — one that integrates lived experience, self‑advocacy, resilience and a deeper understanding of their own health.
These identity transitions matter.
They influence engagement, communication, adherence, mental health and the patient–clinician relationship.
A question for those working in haematology, chronic illness care or rare disease support:
‘How do you see identity shift show up in your patients, and how do you support them through it?‘
Your insights can help shape more compassionate, patient‑centred care.”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention